XML 31 R7.htm IDEA: XBRL DOCUMENT v3.26.1
Consolidated Statements of Cash Flows (Unaudited) - USD ($)
$ in Millions
3 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Operating activities    
Net income/(loss) $ 108.0 $ (42.5)
Adjustments to reconcile net income/(loss) after tax to net cash provided by/(used in) operating activities:    
Share compensation expense 1.7 1.3
Accretion, amortization and depreciation (3.5) (5.8)
Net realized and unrealized (gain)/loss on investments 1.6 (5.9)
Deferred tax expense/(benefit) 2.6 (16.3)
Net changes in assets and liabilities:    
Accrued investment income 4.8 9.0
Premiums and other receivables (710.7) (601.3)
Amounts due from The Fidelis Partnership (32.9) (17.8)
Deferred reinsurance premiums (319.5) (301.1)
Reinsurance balances recoverable on paid losses 17.2 (13.4)
Reinsurance balances recoverable on reserves for losses and loss adjustment expenses (51.7) (228.3)
Deferred policy acquisition costs (287.1) (215.7)
Other assets 105.1 (4.3)
Reserves for losses and loss adjustment expenses 149.0 (43.8)
Unearned premiums 930.2 724.0
Reinsurance balances payable 261.2 264.8
Amounts due to The Fidelis Partnership 95.2 56.1
Other liabilities 2.8 7.9
Net cash provided by/(used in) operating activities 274.0 (433.1)
Investing activities    
Purchase of available-for-sale securities (626.1) (368.8)
Proceeds from maturities of available-for-sale securities 124.0 171.8
Proceeds from sales of available-for-sale securities 399.2 642.0
Proceeds from sale of other investments 5.5 0.0
Purchase of other investments 126.9 0.0
Purchase of fixed assets (0.4) (0.3)
Net cash provided by/(used in) investing activities (224.7) 444.7
Financing activities    
Dividends on common shares (13.3) (11.1)
Repurchase of common shares (219.4) (22.1)
Tax paid on withholding shares (1.4) 0.0
Net cash used in financing activities (234.1) (33.2)
Effect of exchange rate changes on foreign currency cash (0.9) 2.7
Net decrease in cash, restricted cash, and cash equivalents (185.7) (18.9)
Cash, restricted cash, and cash equivalents, beginning of period 1,247.6 946.6
Cash, restricted cash, and cash equivalents, end of period 1,061.9 927.7
Cash, restricted cash, and cash equivalents comprise the following:    
Cash and cash equivalents 895.4 733.4
Restricted cash and cash equivalents 166.5 194.3
Total cash, cash equivalents and restricted cash $ 1,061.9 $ 927.7